These results combined with evidence that oligomeric tau and α-synuclein interact and co-aggregate in disease (Sengupta et al., 2015) suggests that the two proteins may act in a toxic synergistic mechanism at the synapse in AD. The gene discussed is MAPT; the disease is Alzheimer disease.